All-oral shorter treatment regimens for multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB): evaluating their effectiveness, safety, feasibility, cost-effectiveness and impact on the quality of life of patients in Pakistan
Open Access
- 8 February 2021
- dataset
- Published by Springer Nature
Abstract
No abstract availableFunding Information
- World Health Organization